Location of Repository

Identification of functional differences between recombinant human α and β cardiac myosin motors

By John C. Deacon, Marieke J. Bloemink, Heresh Rezavandi, Michael A. Geeves and Leslie A. Leinwand

Abstract

The myosin isoform composition of the heart is\ud dynamic in health and disease and has been shown to affect\ud contractile velocity and force generation. While different\ud mammalian species express different proportions of a and\ud b myosin heavy chain, healthy human heart ventricles\ud express these isoforms in a ratio of about 1:9 (a:b) while\ud failing human ventricles express no detectable a-myosin.\ud We report here fast-kinetic analysis of recombinant human\ud a and b myosin heavy chain motor domains. This represents the first such analysis of any human muscle myosin\ud motor and the first of a-myosin from any species. Our\ud findings reveal substantial isoform differences in individual\ud kinetic parameters, overall contractile character, and predicted cycle times. For these parameters, a-subfragment 1\ud (S1) is far more similar to adult fast skeletal muscle myosin\ud isoforms than to the slow b isoform despite 91% sequence\ud identity between the motor domains of a- and b-myosin.\ud Among the features that differentiate a- from b-S1: the\ud ATP hydrolysis step of a-S1 is *ten-fold faster than b-S1,\ud a-S1 exhibits *five-fold weaker actin affinity than b-S1,\ud and actin a-S1 exhibits rapid ADP release, which is > tenfold faster than ADP release for b-S1. Overall, the cycle\ud times are ten-fold faster for a-S1 but the portion of time\ud each myosin spends tightly bound to actin (the duty ratio)\ud is similar. Sequence analysis points to regions that might\ud underlie the basis for this finding

Topics: Q
Year: 2012
DOI identifier: 10.1007/s00018-012-0927-3
OAI identifier: oai:kar.kent.ac.uk:29670

Suggested articles

Preview

Citations

  1. (2010) Ca2?-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alphamyosin motor gene transfer. doi
  2. (1996). A novel stopped-flow method for measuring the affinity of actin for myosin head fragments using microgram quantities of protein. doi
  3. (2007). A variable domain near the ATP-binding site in Drosophila muscle myosin is part of the communication pathway between the nucleotide and actin-binding sites. doi
  4. (1978). Actin mediated release of ATP from a myosin-ATP complex. doi
  5. (2004). Adenosine diphosphate and strain sensitivity in myosin motors.
  6. (1985). ADP dissociation from actomyosin subfragment 1 is sufficiently slow to limit the unloaded shortening velocity in vertebrate muscle. doi
  7. (2006). Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation. doi
  8. (2003). Analysis of myosin heavy chain functionality in the heart. doi
  9. (1967). ATPase activity of myosin correlated with speed of muscle shortening. doi
  10. (2010). Ca 2?-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alphamyosin motor gene transfer. doi
  11. (2007). Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes. doi
  12. (2004). Cardiac myosin isoforms from different species have unique enzymatic and mechanical properties. doi
  13. (1995). Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. doi
  14. (1995). Chimeric substitutions of the actin-binding loop activate dephosphorylated but not phosphorylated smooth muscle heavy meromyosin. doi
  15. (1999). Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity. doi
  16. (1997). Dictyostelium discoideum myosin II: characterization of functional myosin motor fragments. doi
  17. (1979). Distribution of myosin isoenzymes among skeletal muscle fiber types. doi
  18. (2010). Effects of myosin heavy chain manipulation in experimental heart failure. doi
  19. (1994). Enzymatic activities correlate with chimaeric substitutions at the actin-binding face of myosin. doi
  20. (2005). Expression of eight distinct MHC isoforms in bovine striated muscles: evidence for MHC-2B presence only in extraocular muscles. doi
  21. (2005). Forced expression of alpha-myosin heavy chain in the rabbit ventricle results in cardioprotection under cardiomyopathic conditions. doi
  22. (2010). Functional diversity among a family of human skeletal Functional differences in cardiac myosins 2275 123muscle myosin motors.
  23. (2010). Functional diversity among a family of human skeletal Functional differences in cardiac myosins 2275 muscle myosin motors. doi
  24. (2008). Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone. doi
  25. (1994). How molecular motors work. doi
  26. (1978). Intermediate states of subfragment 1 and actosubfragment 1 ATPase: reevaluation of the mechanism. doi
  27. (2007). Kinetic analysis of the slow skeletal myosin MHC-1 isoform from bovine masseter muscle. doi
  28. (1993). Kinetic characterization of a cytoplasmic myosin motor domain expressed in Dictyostelium discoideum. doi
  29. (1999). Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms. doi
  30. (1998). Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. doi
  31. (1984). Kinetics of the interaction between actin, ADP, and cardiac myosin-S1.
  32. (1995). Maximum speed of shortening and ATPase activity in atrial and ventricular myocardia of hyperthyroid rats.
  33. (1998). Modulation of actin affinity and actomyosin adenosine triphosphatase by charge changes in the myosin motor domain. doi
  34. (2002). Molecular mechanics of mouse cardiac myosin isoforms.
  35. (2003). Mutations in the motor domain modulate myosin activity and myofibril organization. doi
  36. (2002). Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. doi
  37. (2003). Myosin from failing and non-failing human ventricles exhibit similar contractile properties. doi
  38. (1997). Myosin heavy chain gene expression in human heart failure. doi
  39. (2000). Myosin heavy chain isoform expression in the failing and nonfailing human heart. doi
  40. (2008). Myosin I can act as a molecular force sensor. doi
  41. (1999). Myosin II folding is mediated by a molecular chaperonin. doi
  42. Oldfors A (2007) Hereditary myosin myopathies. doi
  43. (1982). Preparation of myosin and its subfragments from rabbit skeletal muscle. doi
  44. (1988). Protein fluorescence changes associated with ATP and adenosine 50-[gamma-thio]triphosphate binding to skeletal muscle myosin subfragment 1 and actomyosin subfragment 1.
  45. (2001). Quantitative electrophoretic analysis of myosin heavy chains in single muscle fibers.
  46. RobbinsJ (2010)Effectsof myosin heavy chain manipulation in experimental heart failure.
  47. (1975). Separation of subfragment-1 isoenzymes from rabbit skeletal muscle myosin. doi
  48. (2002). Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. doi
  49. (1994). Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. doi
  50. (1999). Structural mechanism of muscle contraction.AnnuRevBiochem68:687–728.doi:10.1146/annurev.
  51. (1973). Studies on the heterogeneity of subfragment-1 preparations. Isolation of a new proteolytic fragment of the heavy chain of myosin.
  52. (2007). Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium. doi
  53. (1976). The magnesium-ion-dependent adenosine triphosphatase of bovine cardiac myosin and its subfragment-1.
  54. (1996). The mammalian myosin heavy chain gene family. doi
  55. (1999). The motor protein myosin-I produces its working stroke in two steps.
  56. (1971). The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin.
  57. (2007). The slow skeletal muscle isoform of myosin shows kinetic features common to smooth and non-muscle myosins. doi
  58. (1985). The use of actin labelled with N-(1-pyrenyl)iodoacetamide to study the interaction of actin with myosin subfragments and troponin/tropomyosin.
  59. (2008). Towards a unified theory of muscle contraction. I: foundations. doi
  60. (2006). Two independent mechanical events in the interaction cycle of skeletal muscle myosin with actin. doi
  61. (2006). What limits the velocity of fast-skeletal muscle contraction in mammals? doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.